“PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene
Human Gene Therapy Clinical Development · 2014
DOI: 10.1089/hum.2013.127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2014. Verfasst von Can Yurttas und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yurttas, C., Berchtold, S., Malek, N., Bitzer, M., & Lauer, U. M. (2014). “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2013.127
Vancouver
Yurttas C, Berchtold S, Malek N, Bitzer M, Lauer UM. “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Human Gene Therapy Clinical Development. 2014. doi:10.1089/hum.2013.127
BibTeX
@article{Yurttas2014,
author = {Yurttas, Can and Berchtold, Susanne and Malek, Nisar and Bitzer, Michael and Lauer, Ulrich M.},
title = {“PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene},
journal = {Human Gene Therapy Clinical Development},
year = {2014},
doi = {10.1089/hum.2013.127}
}
EUVIMED